TisCRT-LAPC: A phase II study of tislelizumab combined with nab-paclitaxel and gemcitabine (AG) followed by consolidative radiotherapy in locally advanced pancreatic cancer (LAPC)

被引：0
作者：
Guo, Xi
Zhou, Yuhong
Ji, Yuan
Lou, Wenhui
Wu, Lili
Wang, Wenquan
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16350
引用
收藏
页数：1
相关论文
共 50 条
[1]   Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC) [J].
Olowokure, Olugbenga ;
Torregroza-Sanchez, Maria Patricia ;
Bedoya-Apraez, Ivan Dario .
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) :E16-E18
[2]   Phase II LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients with locally advanced pancreatic cancer (LAPC). [J].
Hammel, Pascal ;
Lacy, Jill ;
Portales, Fabienne ;
Sobrero, Alberto F. ;
Cid, Roberto A. Pazo ;
Mozo, Jose Luis Manzano ;
Mozo, Manzano ;
Terrebonne, Eric ;
Dowden, Scot D. ;
Li, Jack Shiansong ;
Ong, Teng Jin ;
Nydam, Thom ;
Philip, Philip Agop .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
[3]   Gemcitabine (G) plus nab-paclitaxel (nab-P) plus chemoradiation (CRT) in locally advanced pancreatic cancer (LAPC) [J].
Olowokure, Olugbenga Olanrele ;
Bedoya, Ivan Dario ;
Mierzwa, Michelle Lynn ;
Torregroza, Maria Patricia ;
Dwivedi, Alok Kumar ;
Wang, Jiang ;
Smith, Milton T. ;
Schmulewitz, Nathan ;
Kucera, Stephen ;
Choe, Kyuran Ann ;
Ristagno, Ross ;
Rudich, Steven ;
Sussman, Jeffrey J. ;
Ahmad, Syed A. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[4]   International phase II trial of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients with locally advanced pancreatic cancer (LAPC): LAPACT [J].
Philip, P. ;
Kayitalire, L. ;
Nydam, T. ;
Penenberg, D. ;
Hammel, P. .
ANNALS OF ONCOLOGY, 2015, 26
[5]   Sequential neoadjuvant chemotherpy with nab-paclitaxel plus gemcitabine and FOLFIRINOX in locally advanced pancreatic cancer (LAPC): A PILOT study. [J].
Kunzmann, Volker ;
Hartlapp, Ingo ;
Scheurlen, Michael ;
Einsele, Hermann ;
Mueller, Justus ;
Kenn, Werner ;
Steger, Ulrich ;
Germer, Christoph T. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[6]   Phase I study of chemoradiation therapy (nab-paclitaxel/Gemcitabine) in 15 patients with unresectable locally advanced pancreatic cancer (UR-LAPC). [J].
Sueyoshi, Hironari ;
Ioka, Tatsuya ;
Tamura, Takeshi ;
Takada, Ryoji ;
Fukutake, Nobuyasu ;
Ashida, Reiko ;
Ohkawa, Kazuyoshi ;
Takahashi, Hidenori ;
Teshima, Teruki ;
Katayama, Kazuhiro .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
[7]   Interim results of a multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC). [J].
Lacy, Jill ;
Portales, Fabienne ;
Hammel, Pascal ;
Cid, Roberto A. Pazo ;
Mozo, Jose Luis Manzano ;
Kim, Edward Jae-hoon ;
Dowden, Scot D. ;
Borg, Christophe ;
Sastre, Javier ;
Bathini, Venu Gopal ;
Terrebonne, Eric ;
Lopez-Trabada, Daniel ;
Rivera, Fernando ;
Asselah, Jamil ;
Damiani, Azzurra ;
Hwang, Jimmy J. ;
Ong, Teng Jin ;
Nydam, Thom ;
Li, Jack Shiansong ;
Philip, Philip Agop .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[8]   Neoadjuvant nab-paclitaxel and gemcitabine (AG) in borderline resectable (BR) or unresectable (UR) locally advanced pancreatic adenocarcinoma (LAPC) in patients ineligible for FOLFIRINOX [J].
Peterson, Shawn ;
Loaiza-Bonilla, Arturo ;
Ben-Josef, Edgar ;
Drebin, Jeffrey A. ;
Westendorf-Overley, Colleen ;
Anthony, Lowell Brian ;
DeSimone, Philip A. ;
Goel, Gaurav ;
Kudrimoti, Mahesh R. ;
Dineen, Sean Patrick ;
Tzeng, Ching-Wei David ;
Hosein, Peter J. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[9]   LAPACT: An open-label, multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients (pts) with locally advanced pancreatic cancer (LAPC). [J].
Philip, Philip Agop ;
Lacy, Jill ;
Dowden, Scot D. ;
Sastre, Javier ;
Bathini, Venu Gopal ;
Cardin, Dana Backlund ;
Ma, Wen Wee ;
Sobrero, Alberto F. ;
Koski, Sheryl L. ;
Borg, Christophe ;
Tonini, Giuseppe ;
Rivera, Fernando ;
Hwang, Jimmy J. ;
Knoble, Jeanna L. ;
Al Baghdadi, Tareq ;
Saif, Wasif M. ;
Meiri, Eyal ;
Kayitalire, Louis ;
Li, Jack ;
Hammel, Pascal .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[10]   PANOVA-3: A phase III study of TTFields with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC) [J].
Weinberg, Uri ;
Farber, Ori ;
Giladi, Moshe ;
Bomzon, Zeev ;
Lavy-Shahaf, Gitit ;
Kirson, Eilon D. .
CANCER RESEARCH, 2018, 78 (13)
12345